Afuco™ Anti-Human TIE1 ADCC Therapeutic Antibody (DX-2240), ADCC Enhanced
Anti-TIE1 ADCC Enhanced Antibody (DX-2240) is an ADCC enhanced antibody produced by our Afuco™ platform. DX-2240 is a fully human monoclonal antibody that targets the Tie-1 receptor on tumor blood vessels and has therapeutic potential in numerous oncology indications. In preclinical animal models, DX-2240 has demonstrated activity against a broad range of solid tumor types.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-586CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TIE1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Open under aseptic conditions. |